MARK ROBERTS: Open Payments
NPI 1275565442 · EVERGREEN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,090 in 62 payments from 15 companies in 2025. Trend: 2023 $1,786 · 2024 $1,375 · 2025 $1,090
Food & beverage: $1,071Education: $19
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $213 |
| Lilly USA, LLC | 14 | $195 |
| Otsuka America Pharmaceutical, Inc. | 7 | $141 |
| GlaxoSmithKline, LLC. | 7 | $139 |
| SHIELD THERAPEUTICS INC | 4 | $78 |
| ABBVIE INC. | 4 | $72 |
| Exact Sciences Corporation | 3 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $53 |
| Axsome Therapeutics, Inc. | 2 | $31 |
| PFIZER INC. | 1 | $25 |
Products named: MOUNJARO, REXULTI, TRELEGY ELLIPTA, FARXIGA, ACCRUFER, AIRSUPRA, VRAYLAR, Cologuard Collection Kit.
Industry payments across AL — which companies pay providers there.
